ARCHIVES

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

Young Reappointed BSA Chairman.

November 30, 2007

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011